Lipids

This article is part of the “Less Known Facts About Excipients” series by Philippe Tschopp. Carnauba Wax Excipient: Palm Origin,...

Abstract Background: Lipid nanoparticles are widely investigated as oral drug delivery systems, but their intestinal performance remains difficult to predict based...

Abstract This study optimized the formulation parameters of nanostructured lipid carriers (NLCs) loaded with Origanum vulgare L. essential oil (OEO), produced by...

Abstract Although solid oral dosage forms are widely used in adult drug therapy, age-appropriate formulations for pediatric patients remain limited....

Abstract In the pediatric patient group, there is a constant need for individualized dosage forms with precise and adjustable drug...

Lipid-based excipients from IOI Oleo help to improve the bioavailability of poorly soluble active ingredients. The majority of new active...

Abstract Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic...

See the poster by RCPE and IOI Oleo: Lipids: Enormous potential impaired with tough challenges This work investigates the solid-state...

Abstract Background: The therapeutic potential of many natural products, including curcumin (CUR), betulinic acid (BA), and oleanolic acid (OA), is limited...

IOI Oleo launched a new family of functional, lipid-based excipients, the polyglycerol esters at CPhI 2025. As the CPhI 2026...